EP PerMed Logo

EP PerMed Newsletter 05 | 16 December 2024

Dear subscribers,

we are pleased to share the fifth edition of the EP PerMed newsletter with you. In this edition, you'll find the announcement of our Joint Transnational Call (JTC) 2025, as well as our Fast Track and Venture Creator Calls, updates on our recent activities and news of general interest in the personalised medicine field. We look forward to sharing our progress and insights with you.

The EP PerMed Consortium

EP PerMed News

16 December 2024

image

EP PerMed JTC2025 Announcement - Pharmacogenomic Strategies for Personalised Medicine Approaches (PGxPM2025)

EP PerMed announces its JTC2025. In total, 35 funding organisations from 24 countries participate in this call with an available budget of over 36.5 Mio. € (approx.).

Read more

11 December 2024

image

New Fast Track and Venture Creator Programmes

EP PerMed introduces two exciting opportunities for start-ups, researchers, and early-stage teams working on cutting-edge solutions in personalised medicine. These programmes aim to accelerate the development, validation, and market readiness of transformative innovations that enhance patient care.

Read more

10 December 2024

image

EP PerMed Conference 2025 - Registration open!

EP PerMed will organise its first EP PerMed Conference on Personalised Medicine Research on 11 and 12 February 2025 in Berlin (Germany), followed by a Training Workshop on 12 and 13 February. Registration for both events is now open.

Read more

20 November 2024

image

Database for Projects in Personalised Medicine Research and Innovation

EP PerMed has launched a project database on transnational research and innovation projects in personalised medicine funded by EP PerMed and the predecessor ERA PerMed.

Read more

12 November 2024

image

EP PerMed Training on Scientific Integrity

The application process for our "EP PerMed Training on Scientific Integrity" is now open! The workshop is specifically tailored to the personalised medicine scientific community (researchers, clinicians and healthcare providers), applying to EP PerMed (and other) potential funding schemes, dealing with ethics compliance considerations, from the submission to the execution phase of their scientific projects.

Read more

Other PM-related News

04 December 2024

image

Action Plan on Strengthening the Collaboration in Personalised Medicine between Africa and Europe

Read more

22 November 2024

image

WHO releases new principles for ethical human genomic data collection and sharing

Read more

See all News

Events

09 January 2025 - EP PerMed JTC2025 Information Day

21 January 2025 - Webinar on the EP PerMed Fast Track Call

28 January 2025 - Webinar on the EP PerMed Venture Creation Call

11 and 12 February 2025 - EP PerMed Conference on Personalised Medicine Research

12 and 13 February 2025 - EP PerMed Training on Scientific Integrity

22 and 23 February 2025 - Sahlgrenska Global Health Hackathon

5 to 7 March 2025 - RE(ACT) Congress & IRDiRC Conference 2025

See all Events

EP PerMed has received funding from the European Union's Horizon Europe research and innovation programme under grant agreement No 101137129.

Imprint

EP PerMed is coordinated by:
DLR Projektträger
Health | Innovations for Disease Control
Heinrich-Konen-Straße 1
53227 Bonn, Germany

phone +49 228 3821-1144
e-mail: eppermed@dlr.de

www.eppermed.eu | LinkedIn | www.DLR-PT.de

For information about data protection, please see our Privacy Policy

You receive this email because you have registered for the EP PerMed Newsletter. If you want to unsubscribe please click here.